Insecticides (India) Ltd FY26 Results

Insecticides (India) Ltd reported FY26 Revenue from Operations at ₹2,140 crore, a 7% increase from ₹2,000 crore in FY25. Gross Profit rose 5% to ₹675 crore, and EBITDA grew 3% to ₹227 crore. However, Profit After Tax (PAT) saw a marginal decline to ₹139 crore from ₹142 crore in the previous fiscal year, attributed to increased tax provisions.

Reader Takeaway: Revenue growth driven by new launches; PAT pressure from costs.

What just happened

The company announced its financial results for the fiscal year ending March 2026. Consolidated revenue from operations increased by 7% to ₹2,140 crore. While gross profit and EBITDA showed modest growth, PAT experienced a slight dip. A significant increase in finance costs, more than doubling to ₹16.87 crore from ₹6.86 crore, was a key factor impacting profitability.

Why this matters

While top-line growth is positive, the dip in PAT and the substantial rise in finance costs are key concerns for investors. The increased finance costs are linked to higher inventory levels and internal investments in new products. The company's ability to manage these costs and pass on raw material price increases will be crucial for future profitability.

The backstory

Insecticides (India) Ltd has been focusing on premiumization and R&D, launching over 25 products in the last three years. This strategy aims to drive long-term growth. The company is also establishing a new agri-science platform, Kaeros, to expand its distribution network and reach new market segments.

What changes now

The company aims to reduce finance costs by 25%-30% and is working on improving supply chain effectiveness through its Kaeros subsidiary. Investors will be closely watching the execution of these strategies and their impact on the company's financial health in the upcoming fiscal year.

Risks to watch

Key risks include high inventory levels (near ₹800 crore) which increase working capital needs and finance costs. Raw material inflation, particularly for crude-linked products, poses a threat to margins. Additionally, dependence on monsoon patterns introduces climate-related risks that could impact demand.

Peer comparison

While specific peer data was not provided in the filing, Insecticides (India) Ltd operates in the agrochemical sector, facing competition from both domestic and international players. Its focus on patented and combination products indicates a strategy to differentiate from commodity-based offerings.

Context metrics (time-bound)

• Revenue from Operations: ₹2,140 crore (FY26) vs ₹2,000 crore (FY25)
• Profit After Tax (PAT): ₹139 crore (FY26) vs ₹142 crore (FY25)
• Finance Cost: ₹16.87 crore (FY26) vs ₹6.86 crore (FY25)
• Inventory: Elevated near ₹800 crore

What to track next

Investors should monitor the company's progress in reducing inventory levels and finance costs. The success of the Kaeros subsidiary in expanding market reach and the impact of seasonal monsoon patterns on sales will be key indicators to watch in the coming quarters.